AU1513699A - Physically stable and x-ray amorphous form of hydrochloride ranitidine having anincreased antitumoral activity and method for producing the same - Google Patents
Physically stable and x-ray amorphous form of hydrochloride ranitidine having anincreased antitumoral activity and method for producing the sameInfo
- Publication number
- AU1513699A AU1513699A AU15136/99A AU1513699A AU1513699A AU 1513699 A AU1513699 A AU 1513699A AU 15136/99 A AU15136/99 A AU 15136/99A AU 1513699 A AU1513699 A AU 1513699A AU 1513699 A AU1513699 A AU 1513699A
- Authority
- AU
- Australia
- Prior art keywords
- anincreased
- producing
- same
- amorphous form
- physically stable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title 1
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 title 1
- 229960000620 ranitidine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/RU1998/000269 WO2000010562A1 (en) | 1998-08-18 | 1998-08-18 | Physically stable and x-ray amorphous form of hydrochloride ranitidine having an increased anti-ulcer activity and method for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1513699A true AU1513699A (en) | 2000-03-14 |
Family
ID=20130252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU15136/99A Abandoned AU1513699A (en) | 1998-08-18 | 1998-08-18 | Physically stable and x-ray amorphous form of hydrochloride ranitidine having anincreased antitumoral activity and method for producing the same |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU1513699A (en) |
| RU (2) | RU2203048C2 (en) |
| WO (1) | WO2000010562A1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it |
| GB9019875D0 (en) * | 1990-09-11 | 1990-10-24 | Glaxo Group Ltd | Pharmaceutical compositions |
| CA2157190A1 (en) * | 1993-03-05 | 1994-09-15 | Wilfried Fischer | Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation |
| DE9420259U1 (en) * | 1994-12-17 | 1995-02-09 | Röhm GmbH, 64293 Darmstadt | Debittered ranitidine preparation |
| RU2083203C1 (en) * | 1995-01-31 | 1997-07-10 | Зайцев Василий Тихонович | Antiulcer agent |
-
1998
- 1998-08-18 RU RU2001105137/14A patent/RU2203048C2/en active IP Right Maintenance
- 1998-08-18 WO PCT/RU1998/000269 patent/WO2000010562A1/en not_active Ceased
- 1998-08-18 RU RU2001105137/15K patent/RU2385155C2/en not_active IP Right Cessation
- 1998-08-18 AU AU15136/99A patent/AU1513699A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000010562A8 (en) | 2001-03-15 |
| RU2203048C2 (en) | 2003-04-27 |
| RU2385155C2 (en) | 2010-03-27 |
| WO2000010562A1 (en) | 2000-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2480900A (en) | Absorbent structure and method for production | |
| AU2466099A (en) | Pharmaceutically active compounds and methods of use thereof | |
| AU4429500A (en) | Electrode structure for iontophoresis devices and method of producing the same | |
| AU2111199A (en) | Benzenesulfonamides and benzamides as therapeutic agents | |
| AU6746800A (en) | Carbon-reinforced electrode and method of making same | |
| AP2000001869A0 (en) | Pharmaceutically active morpholinol | |
| EP1115396A4 (en) | Pharmaceutically active compounds and methods of use thereof | |
| AU7275000A (en) | Absorbent body for an absorbent product and methods for producing an absorbent body | |
| AU4829400A (en) | Battery grid and method of making | |
| AU6056500A (en) | Process and composition for temporarily suppressing pain | |
| AU2380595A (en) | Biologically active composition | |
| AU3938299A (en) | Method of altering heartbeat | |
| PL349393A1 (en) | Sulphonyloxazolamines as therapeutic active ingredients | |
| AU5965399A (en) | Pharmaceutically active composition | |
| AU7416700A (en) | Insulating shaped body and method for producing the same | |
| AU4981199A (en) | Compositions and methods for modulating sexual activity | |
| AU2662799A (en) | Modified pharmacologically active agents and improved therapeutic methods employing same | |
| AU3620300A (en) | Catalyst structure and method of manufacture | |
| AU4651900A (en) | Methods and compositions for modulating ciliary neurotrophic factor activity | |
| AU1513699A (en) | Physically stable and x-ray amorphous form of hydrochloride ranitidine having anincreased antitumoral activity and method for producing the same | |
| AU3702399A (en) | Catalytically active structure | |
| AU2420101A (en) | Method and composition for the treatment of pain | |
| AU8621398A (en) | Method and device for capsulating active ingredients | |
| PL344041A1 (en) | Substituted sulphonyl cyanamides, method for producing same and their use as medicament | |
| AU6230499A (en) | Method for preparing 2-chloropropionaldehyde and use of the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |